Received Aug 25, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMRV | MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) | MERCK & CO. INC. | 2 | Y019171 | OT / RA |
No additional AE/No PQC.; Vaccine was given prior to known temperature excursion.; This spontaneous report was received from a nurse and refers to a 5-year-old female patient. The patient's medical history and concurrent conditions were none. Concomitant therapies were not reported. On 08-Apr-2025, the patient received the second dose of Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) (lot #Y019171, expiration date: 18-May-2026, 1 dosage form, formulation and strength were not reported) administered via intramuscular in right arm for prophylaxis. The vaccine was reconstituted with sterile diluent (MERCK STERILE DILUENT) (lot # and expiration date were not provided). Temperature excursion of freezer, it occurred as a result of a reading from a Digital Data Logger. As determined by manufacturer, vaccine not supported for use. The vaccine was given prior to known temperature excursion (Product storage error). The vaccine purchased with public funds. The patient vaccinated at private doctor's office/hospital. Operator was a trained healthcare professional. The vaccine sharp discarded after giving. No additional adverse event (AE). The is one of several reports from the same reporter.
Comments: none
Sterile Diluent